Ansa Biotechnologies: Jason Gammack, Dan Lin-Arlow

Ansa Biotechnologies, a DNA synthesis technology company, has appointed Jason Gammack as CEO. Founding CEO Dan Lin-Arlow will remain with the company and transition to a new position as CSO.

Gammack has more than 30 years of life sciences industry experience. Most recently, he cofounded and was CEO of Resolve Biosciences, a multiplex spatial analysis firm. Prior to that, he was chief commercial officer at Inscripta. He has also held leadership positions at Qiagen, Ingenuity Systems, Sigma-Aldrich, Invitrogen/Life Technologies, Affymetrix, and Promega.